Lonial, Sagar

Clinical perspectives on the optimal use of lenalidomide plus bortezomib and dexamethasone for the treatment of newly diagnosed multiple myeloma

Richardson, P. G., Durie, B. G., Rosiñol, L., Mateos, M.-V., Dispenzieri, A., Moreau, P., Kumar, S., Raje, N., Munshi, N., Laubach, J. P., et al. (2023) · Haematologica

Multiple Myeloma Research and TreatmentsBone health and treatments

Cited by 9

Risk of Infections in Multiple Myeloma Patients Treated with Bispecific Antibodies

Cani, L., Scott, S. A., Joseph, N. S., Hofmeister, C. C., Gupta, V. A., Dhodapkar, M. V., Lonial, S., Nooka, A. K., & Kaufman, J. L. (2024) · Blood

Multiple Myeloma Research and TreatmentsMonoclonal and Polyclonal Antibodies Research

Cited by 9

Immune-aging is linked to clinical malignancy, racial ancestry, and vaccine responses in myeloma

Potdar, S. V., Kapadia, S., Azeem, M. I., Radzievski, R., Lakhani, K., Joseph, N. S., Kaufman, J. L., Hofmeister, C. C., Gupta, V. A., Lonial, S., et al. (2025) · Blood Advances

Multiple Myeloma Research and TreatmentsT-cell and B-cell Immunology

Cited by 7